Xuenong Ouyang
Shanghai University of Traditional Chinese Medicine(CN)Shanghai Traditional Chinese Medicine Hospital(CN)Seventh People's Hospital of Shanghai(CN)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Gastric Cancer Management and Outcomes, Lung Cancer Diagnosis and Treatment, Cancer-related gene regulation, Lymphoma Diagnosis and Treatment
Most-Cited Works
- → Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Apatinib in Patients With Chemotherapy-Refractory Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction(2016)985 cited
- → Efficacy and Tolerability of First-Line Cetuximab Plus Leucovorin, Fluorouracil, and Oxaliplatin (FOLFOX-4) Versus FOLFOX-4 in Patients With RAS Wild-Type Metastatic Colorectal Cancer: The Open-Label, Randomized, Phase III TAILOR Trial(2018)255 cited
- → IL-1β-induced activation of p38 promotes metastasis in gastric adenocarcinoma via upregulation of AP-1/c-fos, MMP2 and MMP9(2014)143 cited
- → Over Expression of ID-1 in Prostate Cancer(2002)130 cited
- → Programmed Death-Ligand 1 Expression Predicts Tyrosine Kinase Inhibitor Response and Better Prognosis in a Cohort of Patients With Epidermal Growth Factor Receptor Mutation-Positive Lung Adenocarcinoma(2015)123 cited